Medical News

RSS

Toshiba's Aquilion ONE dynamic volume CT system to improve stroke diagnosis, treatment

Containing costs while delivering high-quality, effective care is a directive of healthcare reform. Episode-based care is part of the reform mandate and is a payment approach that reimburses on expected costs for clinically defined episodes rather than fee-for-service.

7 Feb 2011

The Lancet journal publishes BENLYSTA BLISS-52 study against SLE

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced publication of the BLISS-52 study of BENLYSTA in autoantibody-positive patients with active systemic lupus erythematosus in The Lancet.

7 Feb 2011

UHS to acquire Emergent Group/PRI Medical for $70 million

Emergent Group Inc, a leading provider of mobile medical lasers and surgical equipment through its wholly owned subsidiary, PRI Medical Technologies, Inc., today announced that it has signed a definitive agreement with Universal Hospital Services, Inc., whereby UHS will make a cash tender offer of $8.46 per share for all outstanding shares of Emergent Group after a customary "go-shop" period of 21 days.

7 Feb 2011

The Pain Channel releases second episode on professional bowling injuries

Professional football has recently come under scrutiny for the lingering effects of injuries caused by years of high-impact collisions, but doctors are quick to point out that football is not the only sport where athletes are suffering intense physical pain. One of the most physically demanding sports, according to medical experts, is professional bowling.

7 Feb 2011

Synexus wins first contract to conduct ophthalmology studies

Synexus, the world's largest company responsible for the recruitment and running of clinical trials, has won its first contract to conduct ophthalmology studies.

From AES - Accelerated Enrollment Solutions 7 Feb 2011

Integra LifeSciences launches Integra Allograft Cancellous Sponge

Integra LifeSciences Holdings Corp announced today the launch of Integra Allograft Cancellous Sponge, a compressible bone graft composed of 100% cancellous bone. The sponge-like handling characteristics of Integra Allograft Cancellous Sponge allow it to absorb fluids like saline, blood or bone marrow aspirate.

7 Feb 2011

Human Vaccines journal publishes paper on Inovio's new DNA vaccine delivery technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in the scientific journal Human Vaccines.

7 Feb 2011

Patients with kidney tumours can benefit from nephron-sparing surgery

Patients with kidney tumours larger than four centimetres are much more likely to enjoy good long-term renal function if they undergo nephron-sparing surgery rather than radical nephrectomy, according to a study in the February issue of the urology journal BJUI.

7 Feb 2011

Pfizer enters definitive agreement to purchase Ferrosan's consumer healthcare business

Pfizer Inc. today announced that it has entered into a definitive agreement to purchase Ferrosan's consumer healthcare business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited.

7 Feb 2011

British Journal of Dermatology publishes data on DermTech's new genomic assay for melanoma

DermTech International, a biotechnology company dedicated to bringing genomic medicine to dermatologists, today announced that the discovery data on its new genomic assay for melanoma have been published in the British Journal of Dermatology.

7 Feb 2011

Curaxis President comments on new Alzheimer's Association report

Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp., commented today on a new report by the Alzheimer's Association, titled "Generation Alzheimer's – the defining disease of the baby boomers", which demonstrates the devastating impact and size of Alzheimer's disease.

7 Feb 2011

Court filings: Tobacco companies seek to block public disclosure of proposed statements

According to court filings, the tobacco companies are seeking to block public disclosure of proposed statements a federal judge has ordered them to make to correct their deceptions about their deadly products.

7 Feb 2011

Baden-W-rttemberg's study and research to be presented at AAAS Annual Meeting 2011

Baden-W-rttemberg, the German Southwest, is the most innovative region in Europe, particularly dedicated to science and education. A share of 4.4 % of the State's GDP is invested in research and development - more than in most countries all around the world. Baden-W-rttemberg offers the highest density of research institutions and universities in Germany.

7 Feb 2011

Allergies appear to reduce glioma risk

The more allergies one has, the lower the risk of developing low- and high-grade glioma, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

7 Feb 2011

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

EpiCept Corporation today announced positive results from a Phase IIb trial evaluating the efficacy and safety of EpiCept NP-1 in chemotherapy-induced peripheral neuropathy. EpiCept NP-1 is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

7 Feb 2011

Pediatric physicians present 12 research abstracts, posters at Cardiology 2011

Pediatric cardiology researchers and clinicians gather this week in Scottsdale, Ariz. for Cardiology 2011, the 15th Annual Update on Pediatric and Congenital Cardiovascular Disease, sponsored by The Children's Hospital of Philadelphia. Original research from more than 30 cardiac programs in the U.S. and abroad is being presented throughout the meeting.

7 Feb 2011

TS Wiley develops HRT protocol using Idiom Decision Manager tool

The Wiley Protocol is a trademarked, patent protected bio-identical hormone replacement therapy delivery system consisting of biomimetic estradiol and progesterone in a topical cream preparation – dosed to mimic the natural hormones produced by a woman's body when she was in her prime. The Wiley Protocol is the brainchild of TS Wiley, a popular author and frequent speaker at medical seminars around the world.

7 Feb 2011

Genomic study identifies link between Native American ancestry, relapse in young leukemia patients

The first genome-wide study to demonstrate an inherited genetic basis for racial and ethnic disparities in cancer survival linked Native American ancestry with an increased risk of relapse in young leukemia patients. The work was done by investigators at St. Jude Children's Research Hospital and the Children's Oncology Group.

6 Feb 2011

Health reform law court decision sparks more political maneuvering

As some news outlets cover the fallout from the Florida court decision on the legality of the health law, others examined aspects of the law, including the provision about "mini-med" insurance plans.

6 Feb 2011

New research: Binge drinking in rural areas is more of a problem than previously thought

Binge drinking is often considered to be a problem of towns and cities but new research published in BioMed Central's open access journal BMC Public Health shows that binge drinking in rural areas is more of a problem than previously thought.

6 Feb 2011

Medical News

Toshiba's Aquilion ONE dynamic volume CT system to improve stroke diagnosis, treatment

The Lancet journal publishes BENLYSTA BLISS-52 study against SLE

UHS to acquire Emergent Group/PRI Medical for $70 million

The Pain Channel releases second episode on professional bowling injuries

Synexus wins first contract to conduct ophthalmology studies

Integra LifeSciences launches Integra Allograft Cancellous Sponge

Human Vaccines journal publishes paper on Inovio's new DNA vaccine delivery technology

Patients with kidney tumours can benefit from nephron-sparing surgery

Pfizer enters definitive agreement to purchase Ferrosan's consumer healthcare business

British Journal of Dermatology publishes data on DermTech's new genomic assay for melanoma

Curaxis President comments on new Alzheimer's Association report

Court filings: Tobacco companies seek to block public disclosure of proposed statements

Baden-W-rttemberg's study and research to be presented at AAAS Annual Meeting 2011

Allergies appear to reduce glioma risk

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

Pediatric physicians present 12 research abstracts, posters at Cardiology 2011

TS Wiley develops HRT protocol using Idiom Decision Manager tool

Genomic study identifies link between Native American ancestry, relapse in young leukemia patients

Health reform law court decision sparks more political maneuvering

New research: Binge drinking in rural areas is more of a problem than previously thought

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News